This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients With Head and Neck Cancer Who Are Treated With BI 754091
Clinical trial NCT03780725 · TERMINATED
Trial details
- NCT number
- NCT03780725
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-22
- Primary completion
- 2020-02-19
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.